Cleared Traditional

K163259 - AXS Offset Delivery Assist Catheter

K163259 is the FDA 510(k) clearance for AXS Offset Delivery Assist Catheter by Stryker Neurovascular. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Traditional 510(k) pathway after a 249-day FDA review.

K163259 · Stryker Neurovascular · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2017
Decision
249d
Days
Class 2
Risk

K163259 is an FDA 510(k) clearance for the AXS Offset Delivery Assist Catheter. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Stryker Neurovascular (Fremont, US). The FDA issued a Cleared decision on July 28, 2017 after a review of 249 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Stryker Neurovascular devices

Submission Details

510(k) Number K163259 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 21, 2016
Decision Date July 28, 2017
Days to Decision 249 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
124d slower than avg
Panel avg: 125d · This submission: 249d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 574
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K163259.
Attain Assist CS Access Catheter
K171819 · Creganna Medical Also Doing Business AS Ceganna Tactx Medica · Jan 2018
GuideLiner V3 Catheter
K172090 · Vascular Solutions, Inc. · Oct 2017
MAMBA and MAMBA FLEX Microcatheters
K171452 · Boston Scientific Corporation · Aug 2017
Rubicon 14, 18 and 35 Support Catheters
K171913 · Boston Scientific Corporation · Jul 2017
YOGA Microcatheter, 0.032, 150cm, Back Up and Extra Back Up
K171653 · Codman & Shurtleff, Inc. · Jul 2017
ACUITY Pro Lead Delivery System
K171612 · Boston Scientific Corporation · Jun 2017